Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Advanced purification of Abiraterone acetate via oxalate salt formation. Eliminates column chromatography, ensures >99.5% purity, and offers scalable manufacturing solutions.
Patent CN107129476B details a high-yield synthesis route for this pharmaceutical intermediate, offering significant supply chain stability and cost reduction in pharmaceutical intermediates manufacturing through mild conditions.
Patent CN1491951A reveals novel asymmetric hydrogenation and microbial routes for high-purity azepine intermediates, offering significant cost reduction in pharmaceutical manufacturing.
Discover advanced catalytic methods for pyrimidylcyclopentane intermediates. Enhance purity and reduce costs in AKT inhibitor manufacturing with our scalable solutions.
Patent CN107501266A details a novel Pd-catalyzed asymmetric allylic amination route for high-purity nucleoside intermediates, offering significant supply chain and cost advantages.
Novel synthesis of benzodiazepine compound via intermediate K. High yield, simplified purification, cost-effective manufacturing for pharmaceutical supply chains.
Patent CN101508672B details a resin-catalyzed esterification method for 1,4-dihydropyridines, offering high purity and scalable production for cardiovascular drug manufacturers.
Explore the novel synthesis of taspinine biphenyl derivatives with antitumor activity. Discover cost-effective manufacturing routes and reliable supply chain solutions for API intermediates.
Patent CN110577482B reveals a novel 2-step one-pot synthesis for Amisulpride. Discover cost-effective manufacturing, high purity yields, and reliable supply chain solutions.
Novel non-aqueous synthetic method for 2-thiophene ethylamine ensures high purity and green manufacturing for cardiovascular drug intermediates supply chain.
Advanced purification method for Tedizolid Phosphate using absolute ethanol. Eliminates high-boiling solvents for superior purity and cost-effective API manufacturing.
Improved synthesis of Bardoxolone lactone derivatives using oleanolic acid. Reduces steps, eliminates heavy metals, ensures high purity for pharmaceutical supply chains.
Patent CN102030798B reveals a novel triflate salt purification method for Abiraterone Acetate. Achieves >97% purity, eliminates chromatography, and ensures scalable supply.
Patent CN116143673B reveals a novel heterogeneous catalyst method for diphenyl sulfide. Achieves high purity and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN104744380B reveals green ionic liquid catalysis for quinazolinones offering significant cost reduction and supply chain reliability for global pharmaceutical intermediate manufacturing.
Novel KMnO4 oxidation route for Roflumilast reduces hazardous waste. Enables cost effective API manufacturing with high purity standards.
Patent CN105037381A enables green synthesis using ionic liquids. Reduces waste and improves supply chain reliability for pharmaceutical intermediate manufacturing globally.
Advanced patent-based synthesis of Cabazitaxel intermediates offering high yield and regioselectivity. Reliable supply chain solutions for complex anticancer drug manufacturing.
Patent CN115894365B reveals a scalable route for morphine intermediates, offering cost reduction and supply chain reliability for pharmaceutical manufacturing partners.
Patent CN110054597B reveals a metal-free route for thiazolidin-4-one derivatives, offering significant cost reduction and high purity for pharmaceutical intermediate manufacturing.